A new study suggests that a new drug, Aducanumab, may help in the fight against Alzheimer’s.
The drug not only decreased the plaques that have been thought to cause Alzheimer’s in most patients but may also contribute to mental recovery.
Only 165 patients were involved in the preliminary study, but the FDA has authorized the drug’s maker, Biogen, to proceed with clinical trials, according to a story in The Sentinel.
The study reported that 60 percent of subjects experienced a reduction in the amount of damaging plaques in the brain.
The subjects received a dose once a month for 54 weeks.
The results were similar to those seen in earlier animal studies.
If you have questions about elder law, feel free to contact us for a consultation at (626) 696-3145.
